FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
Real-time Estimate Tradegate  -  06:33 2022-08-16 am EDT
37.43 EUR   +1.98%
08/15Moody's Keeps Fresenius' Rating Unchanged Despite Operating Headwinds
MT
08/15Moody's Confirms Fresenius Medical Care's Stable Outlook Amid Muted Operating Performance
MT
08/08Credit Suisse Cuts Price Target on Fresenius Medical Care to EUR47 From EUR61, Citing 'Major Margin Pressure,' Keeps Neutral Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA is the world's leading supplier of services and equipment for patients with kidney problems. Net sales break down by activity as follows:

- clinical care services (78.8%): operated, at the end of 2021, 4,171 institutions;

- manufacturing of dialyzers and related products (21.2%): hemo-dialysis and pediatric dialysis machines, etc. The group also offers therapies accompanied by care and treatment for dialysis patients.

Net sales are distributed geographically as follows: Europe/Middle East/Africa (15.7%), North America (68.8%), Asia/Pacific (11.5%) and Latin America (4%).

Number of employees : 122 909 people.
Sales per Business
20202021Delta
North America12 478.4069.9%12 087.7068.6% -3.13%
EMEA2 762.5915.5%2 764.7715.7% +0.08%
Asia-Pacific1 894.1810.6%2 009.7911.4% +6.1%
Latin America684.233.8%702.924% +2.73%
Corporate39.640.2%53.490.3% +34.94%
EUR in Million
Sales per region
20202021Delta
North America12 478.4069.9%12 087.7068.6% -3.13%
Rest of the World4 887.2127.4%5 019.5828.5% +2.71%
Germany493.442.8%511.392.9% +3.64%
EUR in Million
Managers
Name Title Age Since
Rice Powell Chief Executive Officer 66 2013
Helen Giza Chief Financial & Transformation Officer 53 2022
Franklin Maddux Executive VP-Clinical & Scientific Affairs 62 2009
Dominik Heger, Dr. Senior VP, Head-IR & Corporate Communications - 2017
Katarzyna Mazur-Hofsaess, Dr. CEO-Europe, Middle East & Africa 58 2018
William Valle Chief Executive Officer-North America - 2017
Nwamaka Eneanya, Dr. Head-Strategy & Operations-Global Medical Office - 2022
Members of the board
Name Title Age Since
Dieter Schenk Chairman-Supervisory Board 69 2018
Rolf Classon Vice Chairman-Supervisory Board 76 -
Pascale Witz Member-Supervisory Board 55 2016
Gregor ZŘnd, Dr. Member-Supervisory Board 62 2018
Dorothea Wenzel, Dr. Member-Supervisory Board 52 2019
A. Gregory Sorensen, Dr. Member-Supervisory Board 57 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 293,004,339 199,033,067 67.9% 0 0.0% 67.9%
Shareholders
NameEquities%
Fresenius SE & Co. KGaA 94,380,382 32.2%
Harris Associates LP 14,273,039 4.86%
Dodge & Cox 8,828,783 3.01%
Pzena Investment Management LLC 8,824,451 3.01%
Artisan Partners LP 8,785,062 2.99%
Thornburg Investment Management, Inc. 7,849,070 2.68%
Templeton Global Advisors Ltd. 6,656,012 2.27%
The Vanguard Group, Inc. 5,491,834 1.87%
FIL Investment Advisors (UK) Ltd. 4,018,573 1.37%
Norges Bank Investment Management 3,987,475 1.36%
Holdings
NameEquities%Valuation
HUMACYTE, INC. (HUMA) 18,312,735 17.8% 63,728,318 USD
APOLLO MEDICAL HOLDINGS, INC. (AMEH) 800,000 1.43% 42,424,000 USD
Markets and indexes
- Prime Standard
- DAX 40 / FTSE Eurotop 100, PEA, STOXX Europe 600
Stock Exchange Codes
- Bloomberg Code :  FME:GR
- Reuters Code :  FME.DE
- Datastream Code :  
Company contact information
Fresenius Medical Care AG & Co. KGaA
Else-Kr÷ner-Strasse 1
DE-61352 Bad Homburg vor der H÷he, Hessen

Phone : +49 (0) 6172 609 0
Fax :
web site : http://www.fmc-ag.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Fresenius Medical Care AG & Co. KGaA